Teladoc Health, Inc. (TDOC)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 250M 500M 750M Q3 '24: 640.5M Q4 '24: 640.5M Q1 '25: 629.4M Q2 '25: 631.9M Q3 '25: 626.4M Q4 '25: 642.3M Q1 '26: 613.8M Q2 '26: 606.9M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Gross Profit Quarterly

0 30M 60M 90M Q2 '17: 34.6M Q3 '17: 51.9M Q4 '17: 54.4M Q1 '18: 62.8M Q2 '18: 66.9M Q3 '18: 76.8M Q4 '18: 82.7M Q1 '19: 83.9M Q2 '17 Q3 '17 Q4 '17 Q1 '18 Q2 '18 Q3 '18 Q4 '18 Q1 '19

Operating Income Quarterly

-150M -100M -50M 0 50M 100M 150M Q3 '24: -44.4M Q4 '24: -48.2M Q1 '25: -120.6M Q2 '25: -54.4M Q3 '25: -52M Q4 '25: -36M Q1 '26: -61.8M Q2 '26: -37.1M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Net Income Quarterly

-105M -70M -35M 0 35M 70M 105M Q3 '24: -33.3M Q4 '24: -48.4M Q1 '25: -93M Q2 '25: -32.7M Q3 '25: -49.5M Q4 '25: -25.1M Q1 '26: -63.8M Q2 '26: -38.9M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Cost of Revenue Quarterly

0 70M 140M 210M Q3 '24: 179.7M Q4 '24: 188.9M Q1 '25: 196.8M Q2 '25: 190.5M Q3 '25: 187.2M Q4 '25: 197M Q1 '26: 197.5M Q2 '26: 190.8M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating Cash Flow Quarterly

0 40M 80M 120M Q3 '24: 110.2M Q4 '24: 85.9M Q1 '25: 15.9M Q2 '25: 91.4M Q3 '25: 99.3M Q4 '25: 87.7M Q1 '26: 9.5M Q2 '26: 64.7M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Free Cash Flow Quarterly

0 40M 80M 120M Q3 '24: 108.6M Q4 '24: 79.8M Q1 '25: 13.2M Q2 '25: 90.2M Q3 '25: 97M Q4 '25: 85.1M Q1 '26: 7.9M Q2 '26: 63.7M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 70M 140M 210M Q1 '24: 167.7M Q2 '24: 170.2M Q3 '24: 171.5M Q1 '25: 174.2M Q2 '25: 175.9M Q3 '25: 176.9M Q1 '26: 179.1M Q2 '26: 181M Q1 '24 Q2 '24 Q3 '24 Q1 '25 Q2 '25 Q3 '25 Q1 '26 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-7.50 -5.00 -2.50 0.00 2.50 5.00 7.50 Q3 '24: -5.77 Q4 '24: -5.86 Q1 '25: -5.90 Q2 '25: -1.17 Q3 '25: -1.26 Q4 '25: -1.14 Q1 '26: -0.97 Q2 '26: -0.99 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.